Tzu-ping Lin
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Gut microbiota signatures associated with spermatogenic capacity and sperm retrieval outcomes in non-obstructive azoospermia.
Journal: Journal of assisted reproduction and genetics
Published: May 08, 2026
Robotic versus laparoscopic radical nephroureterectomy for upper tract urothelial carcinoma: comparable oncologic outcomes with reduced intravesical recurrence in pathological T3 disease.
Journal: Journal of robotic surgery
Published: April 03, 2026
Real-world comparative outcomes of darolutamide- versus abiraterone-based triplet therapy for metastatic hormone-sensitive prostate cancer: a retrospective cohort study.
Journal: Therapeutic advances in urology
Published: March 07, 2026
Quantifying temperature reduction and expansion range of urban green spaces.
Journal: International journal of biometeorology
Published: December 22, 2025
Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.
Journal: Urologic oncology
Published: April 29, 2025
Taiwan Consensus for the Management of Cardiovascular Risks and Complications in Patients with Prostate Cancer.
Journal: Acta Cardiologica Sinica
Published: January 16, 2025
Renal arterial pseudoaneurysm after robotic-assisted partial nephrectomy: a single-center analysis.
Journal: World journal of urology
Published: January 14, 2025
The influence of shading facilities on outdoor thermal comfort, pedestrian walking speed, and indoor satisfaction.
Journal: International journal of biometeorology
Published: January 06, 2025
A prospective study using questionnaires and urodynamic assessments to evaluate bladder function and continence changes after robotic assisted radical prostatectomy.
Journal: Scientific reports
Published: December 09, 2024
Uncovering the Role of ALDH1A2 in Prostate Cancer: Insights from Genetic and Expression Analyses.
Journal: Journal of Cancer
Published: October 05, 2024
PlexinD1 is a driver and a therapeutic target in advanced prostate cancer.
Journal: EMBO molecular medicine
Published: April 09, 2024
Last Updated: 09/26/2026